---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-087326"
form_type: "8-K"
ticker: "CRNX"
cik: "0001658247"
company_name: "Crinetics Pharmaceuticals, Inc."
filed_at: "2024-04-04T23:59:59+00:00"
generated_at: "2026-06-04T02:20:26.495117+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Crinetics adopts non-qualified deferred compensation plan for executives and directors

## Summary
- Plan effective April 1, 2024; allows deferral of salary, fees, bonuses, and time-based RSUs.
- Participation limited to select management, highly compensated employees, and non-employee directors.
- Company may make matching or discretionary contributions; elective deferrals and matching fully vested.
- Payments generally made after separation from service or at elected in-service payment date.

## SEC filing metadata
- accession: 0001193125-24-087326
- form_type: 8-K
- ticker: CRNX
- cik: 0001658247
- company_name: Crinetics Pharmaceuticals, Inc.
- filed_at: 2024-04-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1658247/000119312524087326/0001193125-24-087326-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1658247/000119312524087326/d819564d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-087326
- JSON: https://secwatch.observer/filing/0001193125-24-087326.json
- Plain text: https://secwatch.observer/filing/0001193125-24-087326.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.